Male
Chris Mirabelli joined HealthCare Ventures as a managing director in 2000. Dr. Mirabelli was chairman of the board and chief executive officer of LeukoSite, Inc. from 1993 through 1999, a company in which HealthCare Ventures was the lead investor. He was a co-founder of Isis Pharmaceuticals. He was previously with SmithKline and French Laboratories R&D Division. He is a member of the board of advisors of the Accelerator Fund at Harvard Medical School. He received his Doctor of Philosophy degree in molecular pharmacology from Baylor College of Medicine in Houston, Texas.
Headlines from Google News. Social posts load from the platform only when you open a tab.
Technology Networks · Sep 5
Genetic Engineering and Biotechnology News · Aug 29